Antidepressant adequacy and work status among medicaid enrollees with disabilities: A restriction-based, propensity score-adjusted analysis

Community Mental Health Journal

Volumn 45, Issue 5, 2009, Pages 333-340

  Smith, Eric G ^a   Henry, Alexis D ^a   Zhang, Jianying ^a   Hooven, Fred ^a   Banks, Steven M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antidepressant treatment; Depression; Disability; Employment; Propensity score; Restriction

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; DULOXETINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; VENLAFAXINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISABLED PERSON; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAID; MENTAL DEFICIENCY; PHYSICAL DISABILITY; PRESCRIPTION; SELF REPORT; SEX DIFFERENCE; WORK CAPACITY;

ADULT; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSION; DISABLED PERSONS; EMPLOYMENT; FEMALE; HUMANS; MALE; MASSACHUSETTS; MEDICAID; MIDDLE AGED; PROPENSITY SCORE; TREATMENT OUTCOME; UNITED STATES;

EID: 70349652274     PISSN: 00103853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10597-009-9199-2     Document Type: Article

References (35)

1. DD Addington JM Azorin IR Falloon J Gerlach SR Hirsch SG Siris 2002 Clinical issues related to depression in schizophrenia: An international survey of psychiatrists Acta Psychiatrica Scandinavica 105 189 195 10.1034/j.1600-0447. 2002.1o458.x 11939972 10.1034/j.1600-0447.2002.1o458.x 1:STN:280: DC%2BD383jsVGrsQ%3D%3D (Pubitemid 34280691)
2. L Altshuler T Suppes D Black WA Nolen PE Keck MA Frye S McElroy R Kupka H Grunze J Walden G Leverich K Denicoff D Luckenbaugh R Post 2003 Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year followup The American Journal of Psychiatry 160 1252 1262 10.1176/appi.ajp.160.7.1252 12832239 10.1176/appi.ajp.160.7.1252 (Pubitemid 41070941)
3. American Psychiatric Association. (2000). American psychiatric association practice guidelines for the treatment of patients with major depressive disorder (2nd ed.). Arlington, VA: Author.
4. American Psychiatric Association. (2004). Practice guidelines and resources for treatment of patients with Schizophrenia (2nd ed.). Arlington, VA: Author.
5. R Beasley C Burgess N Pearce K Woodman J Crane 1994 Confounding by severity does not explain the association between fenoterol and asthma death Clinical and Experimental Allergy 24 660 668 10.1111/j.1365-2222.1994.tb00970.x 7953948 10.1111/j.1365-2222.1994.tb00970.x 1:STN:280:DyaK2M%2FktFyjsQ%3D%3D (Pubitemid 24257521)
6. LE Braitman PR Rosenbaum 2002 Rare outcomes, common treatments: Analytic strategies using propensity scores Annals of Internal Medicine 137 693 696 12379071
7. WN Burton CY Chen DJ Conti AB Schultz DW Edington 2007 The association of antidepressant medication adherence with employee disability absences The American Journal of Managed Care 13 105 112 17286530
8. S Clark T Costantino G Rudnitsky CA Camargo 2005 Observational study of intravenous versus oral corticosteroids for acute asthma: An example of confounding by severity Academic Emergency Medicine 12 439 445 10.1111/j.1553-2712.2005.tb01545.x 15860696 10.1111/j.1553-2712.2005.tb01545.x
9. CS Dewa JS Hoch E Lin M Paterson P Goering 2003 Pattern of antidepressant use and duration of depression-related absence from work The British Journal of Psychiatry 183 507 513 10.1192/bjp.183.6.507 14645021 10.1192/bjp.183.6.507 (Pubitemid 37533196)
10. NP Emptage R Strun RL Robinson 2005 Depression and comorbid pain as predictors of disability, employment, insurance status and health care costs Psychiatric Services (Washington, D.C.) 56 468 474 10.1176/appi.ps.56.4.468 (Pubitemid 40471591)
11. JE Garrett SF Lanes J Kolbe HH Rea 1996 Risk of severe life threatening asthma and beta agonist type: An example of confounding by severity Thorax 51 1093 1099 10.1136/thx.51.11.1093 8958891 10.1136/thx.51.11.1093 1:STN:280:DyaK2s7hvVSjug%3D%3D
12. PE Greenberg RC Kessler HG Birnbaum SA Leong SW Lowe PA Berglund, et al. 2003 The economic burden of depression in the United States: How did it change between 1990 and 2000? The Journal of Clinical Psychiatry 64 1465 1475 14728109
13. Henry, A. D., Gallagher, P., Stringfellow, V., Olin, L., Hooven, F., and Himmelstein, J. (2007). Notes from the field: Contemporary strategies for developing surveys of people with disabilities. The MassHealth employment and disability survey. In T. Kroll, D. Kerr, P. Placek, J. Cyril, and G. Hendershot (Eds.), Towards best practices for surveying people with disabilities (Vol. 1, pp. 127-146). Hauppauge, NY: Nova Science Publishers.
14. Henry, A.D., Hooven, F., Averbach, A., Hashemi, L., Zhang, J., Olin, L., et al.(2005). Disability and employment: Findings from the MassHealth employment and disability survey. Final report for Massachusetts medicaid infrastructure and comprehensive employment opportunities grant, Center for Health Policy and Research, University of Massachusetts Medical School.
15. AD Henry F Hooven L Hashemi S Banks R Clark J Himmelstein 2006 Disabling conditions and work outcomes among enrollees in a Medicaid buy-in program Journal of Vocational Rehabilitation 25 2 107 117
16. MM Joffe GA Colditz 1998 Restriction as a method for reducing bias in the estimation of direct effects Statistics in Medicine 17 2233 2249 10.1002/(SICI)1097-0258(19981015)17:19<2233::AID-SIM922>3.0.CO;2-0 9802181 10.1002/(SICI)1097-0258(19981015)17:19<2233::AID-SIM922>3.0.CO;2-0 1:STN:280:DyaK1M%2FhvV2ruw%3D%3D (Pubitemid 28466821)
17. RC Kessler C Barber HG Birnbaum RC Frank PE Greenberg RM Rose, et al. 1999 Depression in the workplace: Effects on short-term disability Health Affairs 18 163 171 10.1377/hlthaff.18.5.163 10495604 10.1377/hlthaff.18.5.163 1:STN:280:DyaK1MvisFKjtg%3D%3D
18. S Kinne DL Patrick DL Doyle 2004 Prevalence of secondary conditions among people with disabilities American Journal of Public Health 94 443 445 10.2105/AJPH.94.3.443 14998811 10.2105/AJPH.94.3.443
19. R Kronick T Gilmer T Dreyfus L Lee 2000 Improving health-based payment for medicaid beneficiaries: CDPS Health Care Financing Review 21 3 29 64 11481767 1:STN:280:DC%2BD3MvjslSgug%3D%3D
20. S McDermott R Moran T Platt S Dasari 2006 Variation in health conditions among groups of adults with disabilities in primary care Journal of Community Health 31 147 159 10.1007/s10900-005-9008-y 16830504 10.1007/s10900-005-9008-y (Pubitemid 43781346)
21. McNeil, J. (2001). Americans with disabilities: Household economic studies, 1997. Washington, DC: US Department of Commerce, Economics and Statistics Administration, US Census Bureau.
22. J Mintz LI Mintz MJ Arruda SS Hwang 1992 Treatments of depression and the functional capacity to work Archives of General Psychiatry 49 761 768 1417427 1:STN:280:DyaK3s%2FjvVSitA%3D%3D
23. M Mitra N Wilber D Allen DK Walker 2005 Prevalence and correlates of depression as a secondary condition among adults with disabilities The American Journal of Orthopsychiatry 75 76 85 10.1037/0002-9432.75.1.76 15709852 10.1037/0002-9432.75.1.76 (Pubitemid 40261731)
24. MA Oquendo E Baca-Garcia A Kartachov V Khait CE Campbell M Richards, et al. 2003 A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression The Journal of Clinical Psychiatry 64 825 833 12934985 1:CAS:528:DC%2BD3sXmsV2nu7Y%3D
25. G Sachs AA Nierenberg JR Calabrese LB Marangell SR Wisniewski L Gyulai, et al. 2007 Effectiveness of adjunctive antidepressant treatment for bipolar depression The New England Journal of Medicine 356 1711 1722 10.1056/NEJMoa064135 17392295 10.1056/NEJMoa064135 1:CAS:528: DC%2BD2sXkslCrtbY%3D (Pubitemid 46658703)
26. SAS Institute, Inc. (2002-2003). SAS for windows, version 9.1. Cary NC: Author.
27. S Schneeweiss AR Patrick T Sturmer MA Brookhart J Avorn M Maclure KJ Rothman RJ Glynn 2007 Increasing levels of restriction in pharmacoepidemiologic database studies of elederly and comparison with randomized trial results Medical Care 45 S131 S142 10.1097/01.mlr.0000244636.54588.2b 17909372 10.1097/MLR.0b013e318070c08e
28. M Schoenbaum J Unutzer D McCaffrey N Duan C Sherbourne KB Wells 2002 The effects of primary care depression treatment on patients' clinical status and employment Health Services Research 37 1145 1158 10.1111/1475-6773.01086 12479490 10.1111/1475-6773.01086 (Pubitemid 35398453)
29. AA Sepehry S Potvin R Elie E Stip 2007 Selective serotonin reuptake inhibitor (SSRI) Add-on therapy for the negative symptoms of schizophrenia: A meta-analysis The Journal of Clinical Psychiatry 68 604 610 17474817 1:CAS:528:DC%2BD2sXlsF2ksr4%3D
30. SH Simpson DT Eurich SR Majumdar RS Padwal RT Tsuyuki J Varney, et al. 2006 A meta-analysis of the association between adherence to drug therapy and mortality British Medical Journal 333 15 18 10.1136/bmj.38875.675486.55 16790458 10.1136/bmj.38875.675486.55
31. MB Stein BJ Cox TO Afifi S-L Belik J Sareen 2006 Does co-morbid depressive illness magnify the impact of chronic physical illnesses? A population-based perspective Psychological Medicine 36 587 596 10.1017/S0033291706007239 16608557 10.1017/S0033291706007239
32. WF Stewart JA Ricci E Chee SR Hahn D Morganstein 2003 Cost of lost productive work time among US workers with disabilities Journal of the American Medical Association 289 3135 3144 10.1001/jama.289.23.3135 12813119 10.1001/jama.289.23.3135 (Pubitemid 37432889)
33. U. S. Department of Health, Human Services. (2005). The Surgeon General's call to action to improve the health and wellness of persons with disabilities. Washington, DC: Author.
34. G Waghorn D Chant C Lloyd 2006 Labor force activity among Australians with musculoskeletal disorders comorbid with depression and anxiety disorders Journal of Occupational Rehabilitation 16 241 252 10.1007/s10926-006-9018-3 16752088 10.1007/s10926-006-9018-3 (Pubitemid 43988385)
35. J Wang PT Donnan 2001 Propensity score methods in drug safety studies: Practice, strengths, and limitations Pharmacoepidemiology and Drug Safety 10 341 344 10.1002/pds.656 11760497 10.1002/pds.656 1:STN:280:DC%2BD38%2FjsVekug%3D%3D (Pubitemid 33040854)